Home About Rick Nemeroff Why Us? Case Results Contact Us
Mesothelioma
Asbestos
Silica
Dangerous Drugs
Serious Personal Injury
Environmental Injuries
Welding Rods
Products Liability
Medical Malpractice
Trial Consulting


For more details, visit www.MesotheliomaMedicalFacts.com

Although there is no cure for mesothelioma, today there are many clinical trials underway to test new drugs and procedures in an effort to control and someday, to cure this disease. 

Clinical trials are research studies that seek to determine whether new approaches are safe and effective in preventing, diagnosing, and treating illness.  Most clinical research involves testing of new drugs or different combinations of new drugs and other treatments.  

Deciding whether or not to participate in a clinical trial is a highly personal matter.  It is important to learn as much as possible about your disease and about the clinical trials that may be available before making this decision.  Your treating physicians and family members should be included in gathering information, but the decision is ultimately the patient’s choice.

There are several benefits of taking part in clinical trials.  You may receive health care from leading medical professionals in the field of cancer research and access to new drugs and other medical resources you might not otherwise have.  However, there are some risks.  New drugs are untested, and may have side effects, or be less effective than current medications, or be completely ineffective.  Some new drugs and procedures may work for other patients and may not be effective against your illness.  Again, the decision to participate is a highly personal one.

All clinical trials or studies are divided into different phases:

Phase I trials usually enroll a small number of people.  Their overall purpose is to test how new drugs or procedures should be administered.

Phase II trials seek to provide early information about whether or not a new drug or procedure works and also give information about the safety and benefits of the drug or procedure.

Phase III trials compare promising new drugs or procedures with the current standard treatment. Large numbers of people from across the nation usually participate in Phase III trials and receive either the new treatment or the standard treatment.

Following is information on several current clinical trials -

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma

 

Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma; epithelial mesothelioma;

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Conditions: advanced malignant mesothelioma; epithelial mesothelioma; recurrent malignant mesothelioma; sarcomatous mesothelioma

Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma

Conditions: epithelial mesothelioma; localized malignant mesothelioma; advanced malignant mesothelioma

Pemetrexed Disodium and Gemcitabine in Treating Patients With Malignant Mesothelioma

Conditions: advanced malignant mesothelioma; epithelial mesothelioma; sarcomatous mesothelioma

EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer

Conditions: malignant ascites; peritoneal cavity cancer; advanced malignant mesothelioma; localized malignant mesothelioma; recurrent malignant mesothelioma

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma

ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Condition: Mesothelioma

Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma

Conditions: localized malignant mesothelioma; advanced malignant mesothelioma; perioperative/postoperative complications; Quality of Life

Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma

Conditions: advanced malignant mesothelioma; recurrent malignant mesothelioma

Experimental Drug SS1(dsFv)-PE38 to Treat Cancer

Conditions: Mesothelioma; Ovarian Neoplasm; Squamous Cell Neoplasm

Treatment of Peritoneal Cancer with Surgery, Perfused Heated Cisplatin, and Chemotherapy

Conditions: Abdominal Neoplasm; Colonic Neoplasm; Mesothelioma; Peritoneal Neoplasm

Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion in Patients with Pulmonary and Pleural Malignancies

Conditions: Small Cell Carcinoma; Mesothelioma; Non-Small-Cell Lung Carcinoma

Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma

Condition: localized malignant mesothelioma

Flavopiridol in Treating Patients With Metastatic or Unresectable Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Mesothelioma, Renal Cell Carcinoma (Kidney Cancer), Squamous Cell Carcinoma of the Head and Neck, Small Cell Lung Cancer, or Invasive Breast Cancer

Conditions: Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; kidney and urinary cancer; thorax and respiratory cancer

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Condition: Cancer


For more information, please call us toll-free at: 1-888-NEM-LAW-1 or click here to complete this online contact form.  We will respond promptly to your inquiry.




Hear Rick discuss his techniques and the changing trends of trial preparation

Click Here


Rick Nemeroff's cutting edge technology and trial techniques

Read about Rick's cutting edge technology and trial techniques in the latest edition of the Sanction by Verdict Systems Newsletter.


Rick Nemeroff will co-chair "Toxic Tort Update."

Rick Nemeroff will co-chair “Toxic Tort Update: Texas” Conference hosted by LexisNexis & Mealeys Publications. Litigation topics to be covered include: Asbestos, Silica, Welding Rods, Benzene and more.  The conference will be held March 9-10, 2006. Click here for more details.


Nemeroff Law Firm launches www.Mesothelioma
MedicalFacts.com


Rick Nemeroff wins $10+Million Verdict in Los Angeles, CA

Rick Nemeroff won a $10,309,000 verdict in Los Angeles, CA on behalf of an 82 year old Navy veteran who is suffering from an asbestos-related mesothelioma. The jury's April 6, 2005 verdict included a finding that punitive damages were also warranted, but the case settled moments before that phase of the trial was to begin.

Rick Nemeroff to speak at National Asbestos Conference on May 5, 2005

Click Here for more information.


Rick Nemeroff appears on CourtTV

Rick appeared on Closing Arguments, hosted by Nancy Grace, to offer his insight and thoughts on a multi-million dollar lawsuit that CourtTV was covering. The episode aired nationwide on January 3, 2005.

VIOXX ALERT

Click here for our special report on Vioxx. Contact Us us Immediately if you or a loved one took Vioxx!



BEXTRA ALERT

Click here for surprising new information about Bextra. Contact Us Immediately if you or a loved one took Bextra!




$10,309,000 - Rick Nemeroff won a verdict in Los Angeles, CA on behalf of an 82 year old Navy veteran who is suffering from an asbestos-related mesothelioma.

$115,000 - Rick Nemeroff won the first Fen Phen trial ever to go to a verdict in the State of California.

$64 Million - Four workers exposed to asbestos in New York.

$55.5 Million Construction worker in Texas exposed to asbestos, develops mesothelioma

$17 Million Seven iron foundry workers exposed to asbestos in Texas

$14 Million Employee exposed to asbestos in New York.

$12.6 Million Pipefitter at Brooklyn Navy Yard develops mesothelioma after exposure to asbestos

$10.4 Million New York workers at powerhouses exposed to asbestos, develop mesothelioma

$9.4 Million Oil refinery workers exposed to toxic chemicals in Baton Rouge, LA

$6.4 Million - Steel plant employee in Cleveland, Ohio exposed to asbestos

$6 Million Worker in Texas exposed to toxic chemicals